col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


32 Results       Page 1

 [1] 
Springer-Verlag: Medical Microbiology and Immunology
  original article Date Title Authors   All Authors
1 [GO] 2023―Oct―04 Comparative genotyping of SARS-CoV-2 among Egyptian patients: near-full length genomic sequences versus selected spike and nucleocapsid regions Rasha Emad, Iman S. Naga
2 [GO] 2023―Aug―10 Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages Andreas Osterman, Franziska Krenn, Maximilian Iglhaut, Irina Badell, Andreas Lehner, Patricia M. Späth, et al. (+16)
3 [GO] 2023―Aug―10 Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -BA.5 Franziska Krenn, Christopher Dächert, Irina Badell, Gaia Lupoli, Gamze Naz Öztan, Tianle Feng, et al. (+14)
4 [GO] 2023―Jul―25 COVID-19 recurrence is related to disease-early profile T cells while detection of anti-S1 IgG is related to multifunctional T cells Camilla Natália O. Santos, Gustavo C. Caldas, Fabricia A. de Oliveira, Angela Maria da Silva, João S. da Silva, Ricardo Luís L. da Silva, et al. (+3)
5 [GO] 2023―Jul―21 Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants Ebene R. Haycroft, Samantha K. Davis, Pradhipa Ramanathan, Ester Lopez, Ruth A. Purcell, Li Lynn Tan, et al. (+12)
6 [GO] 2023―Jun―13 Association of IFIH1 and DDX58 genes polymorphism with susceptibility to COVID-19 Parisa Feizollahi, Mohammad Hossein Zamanian, Sara Falahi, Farhad Salari, Zahra Mahmoudi, Elham Faryadi, et al. (+2)
7 [GO] 2023―Apr―27 The quantity and quality of anti-SARS-CoV-2 antibodies show contrariwise association with COVID-19 severity: lessons learned from IgG avidity Mehrdad Hajilooi, Fariba Keramat, Akram Moazenian, Mohsen Rastegari-Pouyani, Ghasem Solgi
8 [GO] 2022―Dec―30 Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity Ritika Khatri, Gazala Siddqui, Srikanth Sadhu, Vikas Maithil, Preeti Vishwakarma, Bharat Lohiya, et al. (+4)
9 [GO] 2022―Dec―13 A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17 T cell production Fernanda Tereza Bovi Frozza, Tiago Fazolo, Priscila Oliveira de Souza, Karina Lima, Julia Crispim da Fontoura, Théo Souza Borba, et al. (+5)
10 [GO] 2022―Nov―17 SARS-CoV-2 infection in the context of Kawasaki disease and multisystem inflammatory syndrome in children Barbara Anna Folga, Corrinna Jade Karpenko, Bogna Grygiel-Górniak
11 [GO] 2022―Nov―12 Reduced neutralization against Delta, Gamma, Mu, and Omicron BA.1 variants of SARS-CoV-2 from previous non-Omicron infection Paola Pidal, Jorge Fernández, Constanza Airola, Miguel Araujo, Ana María Menjiba, Héctor San Martín, et al. (+7)
12 [GO] 2022―Nov―12 Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests Andreas Osterman, Irina Badell, Christopher Dächert, Nikolas Schneider, Anna-Yasemin Kaufmann, Gamze Naz Öztan, et al. (+13)
13 [GO] 2022―Jul―23 Immune complexes as culprits of immunopathology in severe COVID-19 Philipp Kolb, Sebastian Giese, Reinhard Edmund Voll, Hartmut Hengel, Valeria Falcone
14 [GO] 2022―Jul―02 SARS-CoV-2 herd immunity of the Kyrgyz population in 2021 Anna Y. Popova, Omor T. Kasymov, Vyacheslav Y. Smolenski, Vyacheslav S. Smirnov, Svetlana A. Egorova, Zuridin S. Nurmatov, et al. (+18)
15 [GO] 2022―Jun―13 Blood and saliva SARS-CoV-2 antibody levels in self-collected dried spot samples Laura Lahdentausta, Anne Kivimäki, Lotta Oksanen, Marika Tallgren, Sampo Oksanen, Enni Sanmark, et al. (+7)
16 [GO] 2022―Jun―04 Mouse models in COVID-19 research: analyzing the adaptive immune response Sabrina Clever, Asisa Volz
17 [GO] 2022―Apr―02 Interferon antagonists encoded by SARS-CoV-2 at a glance Jung-Hyun Lee, Lennart Koepke, Frank Kirchhoff, Konstantin M. J. Sparrer
18 [GO] 2022―Mar―02 Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy Amirmasoud Rayati Damavandi, Razieh Dowran, Sarah Al Sharif, Fatah Kashanchi, Reza Jafari
19 [GO] 2022―Feb―20 Impaired detection of omicron by SARS-CoV-2 rapid antigen tests Andreas Osterman, Irina Badell, Elif Basara, Marcel Stern, Fabian Kriesel, Marwa Eletreby, et al. (+15)
20 [GO] 2022―Jan―21 Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants Christopher Dächert, Maximilian Muenchhoff, Alexander Graf, Hanna Autenrieth, Sabine Bender, Helga Mairhofer, et al. (+6)
21 [GO] 2022―Jan―16 Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality Alexander Leatherdale, Sophie Stukas, Victor Lei, Henry E. West, Christopher J. Campbell, Ryan L. Hoiland, et al. (+5)
22 [GO] 2022―Jan―13 Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19 Shuangyan Li, Fuxiaonan Zhao, Jing Ye, Kuan Li, Qi Wang, Zhongchao Du, et al. (+4)
23 [GO] 2021―Oct―04 Influenza and RSV incidence during COVID-19 pandemic-an observational study from in-hospital point-of-care testing Paul Stamm, Ingo Sagoschen, Kerstin Weise, Bodo Plachter, Thomas Münzel, Tommaso Gori, Markus Vosseler
24 [GO] 2021―Sep―25 Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients Davood Rostamzadeh, Sahar Mortezagholi, Maedeh Alinejad, Seyed Reza Jooya, Maryam Eskandarian, Alireza Metvaei, et al. (+4)
25 [GO] 2021―Aug―20 Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern Andreas Osterman, Maximilian Iglhaut, Andreas Lehner, Patricia Späth, Marcel Stern, Hanna Autenrieth, et al. (+10)
26 [GO] 2021―Jul―01 Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings Marek Widera, Sandra Westhaus, Holger F. Rabenau, Sebastian Hoehl, Denisa Bojkova, Jindrich Cinatl, Sandra Ciesek
27 [GO] 2021―May―24 Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test Julian A. F. Klein, Lisa J. Krüger, Frank Tobian, Mary Gaeddert, Federica Lainati, Paul Schnitzler, et al. (+8)
28 [GO] 2021―Apr―15 Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission Friederike Häuser, Martin F. Sprinzl, Kim J. Dreis, Angelique Renzaho, Simon Youhanen, Wolfgang M. Kremer, et al. (+5)
29 [GO] 2021―Apr―03 An update: the emerging evidence of complement involvement in COVID-19 Qin Li, Zi Chen
30 [GO] 2021―Jan―16 Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting Andreas Osterman, Hanna-Mari Baldauf, Marwa Eletreby, Jochen M. Wettengel, Suliman Q. Afridi, Thimo Fuchs, et al. (+8)
31 [GO] 2020―Nov―21 Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19: a systematic review and meta-analysis Szabolcs Kiss, Noémi Gede, Péter Hegyi, Dávid Németh, Mária Földi, Fanni Dembrovszky, et al. (+11)
32 [GO] 2020―Aug―28 Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity Mingfeng Han, Mengyuan Xu, Yafei Zhang, Zhongping Liu, Shasha Li, Tengfei He, et al. (+14)
 [1] 

32 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.015 sec